Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share (EWTX)

CUSIP: 28036F105

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
105,503,387
Total 13F shares
45,681,359
Share change
+45,681,359
Total reported value
$1,477,378,000
Price per share
$32.50
Number of holders
31
Value change
+$1,477,377,994
Number of buys
31

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 28036F105?
CUSIP 28036F105 identifies EWTX - Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of EWTX - Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share (EWTX) as of Q1 2021

As of 31 Mar 2021, Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share (EWTX) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 45,681,359 shares. The largest 10 holders included ORBIMED ADVISORS LLC, Novo Holdings A/S, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P., CITADEL ADVISORS LLC, Cormorant Asset Management, LP, JANUS HENDERSON GROUP PLC, New Leaf Venture Partners, L.L.C., and FMR LLC. This page lists 31 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2021 vs Q4 2025 Across Filers

Q4 2025 holders
197
Q1 2021 holders
31
Holder diff
-166
Investor Q4 2025 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2025 Value $ Q1 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.